CEO of material subsidiary Shilpa Biologicals resigns

Ceo ResignedManagement Changes View source PDF Explain this filing

SHILPAMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.2%Reaction day

₹644.65

prior close

₹644.90

announcement price

After-mkt

timing

Nifty Microcap 250market-0.5%-0.7% vs market

Pharmaceuticals peers, median of 164sector-0.1%-1.1% vs sector

On the reaction day the stock moved 0.7 pts less than Nifty Microcap 250 and 1.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.3

10m

-0.5

15m

-1.3

30m

-1.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.2-0.5-0.7-0.1-1.1

Next day

-3.9-1.5-2.4-1.0-2.9

-2.9-0.9-2.0-0.5-2.4

-0.8-0.6-0.2-0.4-0.3

-5.0-1.8-3.2-1.8-3.2

-6.3-2.4-3.9-2.8-3.5

-3.7-0.7-2.9-1.8-1.8

15d

+14.4+2.4+12.0-1.6+16.0

+25.5+2.9+22.6-1.5+27.0

+45.0+1.2+43.9-1.4+46.4

+45.8+1.2+44.7-3.4+49.2

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 164Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Dr. Sridevi Khambhampaty has resigned as CEO of Shilpa Biologicals Pvt Ltd, a material subsidiary of Shilpa Medicare, effective 15 July 2026. Reason cited is personal commitments. Her resignation letter is dated 15 April 2026, and she will serve the notice period as per company policy.

Likely market impact

CEO exit at key subsidiary may affect biologics business continuity. Watch for replacement announcement.